Dianthus Therapeutics, Inc. /DE/ (DNTH) insider trading

By person

33 insiders · 121 transactions

10.8×

Marino Garcia holds 10.8 times base salary in stock. $6.82M of shares against $630.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Marino Garcia last reported holding, valued at $104.39, the price Common Stock was last bought or sold at on the open market here, on 17 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Garcia Marino

CEO AND PRESIDENT

—

$27.96M (12) scheduled

−$27.96M

65,292

0.1167%

$6.82M

—

Savitz Ryan

EVP, CFO & CBO

—

$14.99M (14) scheduled

−$14.99M

0.0000%

$0.00

—

Randhawa Simrat

EVP, Head of R&D

$52.80K (2)

$15.00M (11) scheduled

−$14.95M

4,000

0.0072%

$417.56K

—

Booth Bruce

Director

$10.00M (1)

$254.42K (1)

+$9.75M

1,250,000

2.23%

$130.49M

—

CARR EDWARD

CHIEF ACCOUNTING OFFICER

—

$5.59M (10) scheduled

−$5.59M

0.0000%

$0.00

—

Veness Adam M

SVP, General Counsel and Sec.

—

$4.63M (5) scheduled

−$4.63M

15,000

0.0268%

$1.57M

—

Third Rock Ventures IV, L.P. entity

10% owner

—

$3.06M (2)

−$3.06M

3,058,204

5.47%

$319.25M

+3,061%

Soteropoulos Paula

Director

—

$2.25M (3) scheduled

−$2.25M

0.0000%

$0.00

—

GARDNER JASON

See Remarks

$6.00K (1)

$1.79M (8)

−$1.79M

651,964

1.17%

$68.06M

−3.3%

Fairmount Funds Management LLC entity

Director

$1.40M (5)

—

+$1.40M

0.0000%

$0.00

—

McGeorge Anne

Director

—

$844.82K (5) scheduled

−$844.82K

0.0000%

$0.00

—

COOKE MICHAEL P.

Chief Scientific Officer

—

$654.33K (14)

−$654.33K

240,523

0.4300%

$25.11M

−16.7%

Read Simon

Director

—

$630.79K (7) scheduled

−$630.79K

0.0000%

$0.00

—

DAVIS JOHN C. JR

See Remarks

—

$508.64K (4) scheduled

−$508.64K

8,304

0.0148%

$866.85K

—

ISACSON CHRISTINA K.

Chief Business Officer

—

$316.64K (3)

−$316.64K

83,786

0.1498%

$8.75M

−16.7%

Atlas Venture Fund X, L.P. entity

10% owner

—

$254.42K (1)

−$254.42K

3,148,399

5.63%

$328.66M

+3,154%

ZDRAVESKI ZORAN

See Remarks

—

$193.45K (2)

−$193.45K

128,009

0.2289%

$13.36M

−5.5%

Scadden David

Director

$99.00K (1)

—

+$99.00K

228,175

0.4079%

$23.82M

+17.9%

Deardorf Caren

Chief Commercial Officer

—

$41.98K (1)

−$41.98K

19,762

0.0353%

$2.06M

—

Beetham Thomas W.

See Remarks

—

$41.07K (1)

−$41.07K

19,897

0.0356%

$2.08M

—

Mahoney Stephen F.

See Remarks

—

$38.60K (1)

−$38.60K

17,264

0.0309%

$1.80M

—

Olson Lisa

See Remarks

—

$38.60K (1)

−$38.60K

14,264

0.0255%

$1.49M

—

Stants Kristen

Chief People Officer

—

$38.60K (1)

−$38.60K

20,264

0.0362%

$2.12M

—

Nichols David Wayne

Chief Technical Officer

—

$38.32K (1)

−$38.32K

14,306

0.0256%

$1.49M

—

Byers Blake

Director

—

3,339,137

5.97%

$348.57M

—

GV 2016 GP, L.L.C.

10% owner

—

3,339,137

5.97%

$348.57M

—

Meng Lei

Director

—

2,717,554

4.86%

$283.69M

+123.2%

MOULDER LEON O JR

Director

—

1,436,745

2.57%

$149.98M

+13.1%

RONNEBERG AMY L

Director

—

593,611

1.06%

$61.97M

—

BONNEY MICHAEL W

Director

—

215,346

0.3850%

$22.48M

+11.3%

Daniel Thomas O

Director

—

101,926

0.1822%

$10.64M

+31.7%

Albers Jeffrey W.

Director

—

4,152

0.0074%

$433.43K

—

Borisy Alexis

Director

—

4,100

0.0073%

$428.00K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Third Rock Ventures IV, L.P.

8 Feb 2023

10% owner

Sell

1,500,000

$0.82

$1.23M

Third Rock Ventures IV, L.P.

7 Feb 2023

10% owner

Sell

2,200,000

$0.83

$1.83M

Nichols David Wayne

16 Sep 2021

Chief Technical Officer

Sell

5,694

$6.73

$38.32K

Olson Lisa

16 Sep 2021

See Remarks

Sell

5,736

$6.73

$38.60K

Beetham Thomas W.

16 Sep 2021

See Remarks

Sell

6,103

$6.73

$41.07K

GARDNER JASON

16 Sep 2021

See Remarks

Sell

14,340

$6.73

$96.51K

Deardorf Caren

16 Sep 2021

Chief Commercial Officer

Sell

6,238

$6.73

$41.98K

Mahoney Stephen F.

16 Sep 2021

See Remarks

Sell

5,736

$6.73

$38.60K

Stants Kristen

16 Sep 2021

Chief People Officer

Sell

5,736

$6.73

$38.60K

GARDNER JASON

10 Jan 2020

See Remarks

Sell

11,200

$15.25

$170.80K

GARDNER JASON

2 Jan 2020

See Remarks

Sell

2,800

$15.10

$42.28K

ZDRAVESKI ZORAN

24 Dec 2019

See Remarks

Sell

7,902

$16.00

$126.43K

ISACSON CHRISTINA K.

24 Dec 2019

Chief Business Officer

Sell

4,463

$16.01

$71.45K

GARDNER JASON

23 Dec 2019

See Remarks

Sell

2,897

$15.10

$43.75K

ISACSON CHRISTINA K.

23 Dec 2019

Chief Business Officer

Sell

9,867

$16.03

$158.17K

ZDRAVESKI ZORAN

23 Dec 2019

See Remarks

Sell

4,181

$16.03

$67.02K

GARDNER JASON

20 Dec 2019

See Remarks

Sell

76,711

$15.16

$1.16M

GARDNER JASON

10 Dec 2019

See Remarks

Sell

4,392

$15.10

$66.32K

COOKE MICHAEL P.

2 Dec 2019

Chief Scientific Officer

Sell

2,500

$13.21

$33.04K

COOKE MICHAEL P.

2 Dec 2019

Chief Scientific Officer

Sell

1,373

$13.31

$18.28K

COOKE MICHAEL P.

2 Dec 2019

Chief Scientific Officer

Sell

3,627

$12.74

$46.20K

COOKE MICHAEL P.

20 Nov 2019

Chief Scientific Officer

Sell

5,000

$12.00

$60.00K

COOKE MICHAEL P.

1 Nov 2019

Chief Scientific Officer

Sell

5,000

$10.67

$53.33K

COOKE MICHAEL P.

1 Oct 2019

Chief Scientific Officer

Sell

5,000

$10.01

$50.06K

COOKE MICHAEL P.

19 Sep 2019

Chief Scientific Officer

Sell

1,656

$12.00

$19.87K

COOKE MICHAEL P.

12 Sep 2019

Chief Scientific Officer

Sell

844

$12.00

$10.13K

COOKE MICHAEL P.

3 Sep 2019

Chief Scientific Officer

Sell

5,000

$10.11

$50.53K

COOKE MICHAEL P.

1 Aug 2019

Chief Scientific Officer

Sell

2,500

$13.41

$33.52K

COOKE MICHAEL P.

1 Aug 2019

Chief Scientific Officer

Sell

5,000

$13.42

$67.11K

COOKE MICHAEL P.

1 Jul 2019

Chief Scientific Officer

Sell

2,500

$14.42

$36.05K

COOKE MICHAEL P.

1 Jul 2019

Chief Scientific Officer

Sell

5,000

$14.39

$71.93K

GARDNER JASON

21 Jun 2019

See Remarks

Sell

12,331

$15.11

$186.32K

ISACSON CHRISTINA K.

21 Jun 2019

Chief Business Officer

Sell

5,415

$16.07

$87.02K

GARDNER JASON

20 Jun 2019

See Remarks

Sell

1,669

$15.10

$25.20K

COOKE MICHAEL P.

17 Jun 2019

Chief Scientific Officer

Sell

7,500

$13.90

$104.27K

Booth Bruce

20 Mar 2019

Director

Sell indirect

14,245

$17.86

$254.42K

Atlas Venture Fund X, L.P.

20 Mar 2019

10% owner

Sell indirect

14,245

$17.86

$254.42K

Show all 121 transactions →

Dianthus Therapeutics, Inc. /DE/

By person

Individual transactions

What was left out